EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2005 • Ameripath Inc • Services-medical laboratories • Florida
This Employment Agreement (“Agreement”) is made and entered into on this 25th day of April, 2003, effective as of April 1, 2003, by and between AMERIPATH, INC., a Delaware corporation (the “Company”), and JEFFREY A. MOSSLER, M.D. (hereinafter, the “Executive”).
To: Dr. Stephen W. Aldred, M.D. From: James C. New, as Chairman and CEO of AmeriPath Subject: Employment Agreement Amendment section on: Retention Bonus Date: February 8, 2001Diagnostic Information Provider • March 18th, 2005 • Ameripath Inc • Services-medical laboratories
Pursuant to our recent discussions, this document memorializes our agreement to amend the Signing & Retention Bonus section of your most recent AMENDMENT TO EMPLOYMENT AGREEMENT dated November 21, 2000.
AGREEMENT AND PLAN OF MERGER BY AND AMONG AMERIPATH, INC., PATHOLOGY ASSOCIATES OF INDIANA, P.C. PATHOLOGY ASSOCIATES, P.C. ALAN HALPERIN, M.D. WOJCIECH SZANIAWSKI, M.D. PAUL CHU, M.D. AND MARK JACOBSON, M.D. DATED AS OF DECEMBER 3, 2004Agreement and Plan of Merger • March 18th, 2005 • Ameripath Inc • Services-medical laboratories • Florida
MERGER AGREEMENT (the “Agreement”), dated as of December 3, 2004, by and among AmeriPath, Inc., a Delaware corporation, or its permitted assigns (“AmeriPath”), Pathology Associates, P.C. a New York professional corporation (the “Practice”), Pathology Associates of Indiana, P.C., an Indiana professional corporation (“Survivor”), Alan Halperin, M.D. (“Halperin”), Wojciech Szaniawski, M.D. (“Szaniawski”), Paul Chu, M.D. (“Chu”) and Mark Jacobson, M.D. (“Jacobson”).
FOURTH AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2005 • Ameripath Inc • Services-medical laboratories
THIS THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (“Third Amendment”) is made this 17th day of July, 2003, by and between DFW 5.01(a) Corporation, a Texas not for profit corporation certified to practice medicine by the Texas Board of Medicine pursuant to Section 5.01(a) of the Texas Medical Practices Act d/b/a AmeriPath Dallas (the “Company”) and Stephen W. Aldred, M.D. (the “Employee”).
AMERIPATH DALLAS EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2005 • Ameripath Inc • Services-medical laboratories • Texas
WHEREAS, prior to the date hereof, the Employee served as an employee of and rendered professional services, as a Doctor of Medicine specializing in Pathology, to one of a group of related Texas entities (the “Unipath Entities”) providing pathology services. Pursuant to a certain Stock Purchase Agreement (the “Purchase Agreement”) dated as of August 21, 1997, which is an otherwise validly enforceable agreement by and among AmeriPath, Inc., a Delaware corporation (“AmeriPath”), and the ultimate beneficial owners and shareholders of the Unipath Entities, all of the capital stock of and interests of, in or to the Unipath Entities has been purchased by and sold, transferred and conveyed to AmeriPath and the Company (the “Acquisition”), effective the date hereof.
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2005 • Ameripath Inc • Services-medical laboratories
THIS AMENDMENT TO EMPLOYMENT AGREEMENT (“Amendment”) is made this 21st day of November, 2000, by and between DFW 5.01 (a) Corporation, a Texas not for profit corporation certified to practice medicine by the Texas Board of Medicine pursuant to Section 5.01(a) of the Texas Medical Practices Act d/b/a AmeriPath Dallas (the “Company”) and Stephen W. Aldred, M.D. (the “Employee”).
THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2005 • Ameripath Inc • Services-medical laboratories
THIS THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (“Third Amendment”) is made this day of November, 2002, by and between DFW 5.01 (a) Corporation, a Texas not for profit corporation certified to practice medicine by the Texas Board of Medicine pursuant to Section 5.01 (a) of the Texas Medical Practices Act d/b/a AmeriPath Dallas (the “Company”) and Stephen W. Aldred, M.D. (the “Employee”).
